Management of diabetic neuropathy

American Journal of Medicine

Volumn 107, Issue 2 SUPPL. 2, 1999, Pages 27-33

  Parry, Gareth J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; MOTOR NERVE CONDUCTION; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SENSORY SYSTEM; ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; PANCREAS TRANSPLANTATION; PREVALENCE; REVIEW; TIME; FOOT ULCER; GLUCOSE HOMEOSTASIS; HYPOGLYCEMIA; LEG AMPUTATION; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NERVE INJURY;

ALDEHYDE REDUCTASE; ENZYME INHIBITOR; ALDOSE REDUCTASE INHIBITOR;

ALDEHYDE REDUCTASE; ANIMALS; BLOOD GLUCOSE; CLINICAL TRIALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENZYME INHIBITORS; HUMANS; PANCREAS TRANSPLANTATION; PREVALENCE; TIME FACTORS;

EID: 0032870516     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00010-8     Document Type: Conference Paper

References (29)

1. Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Ann Neurol. 19:1986;288-290.
2. Pirart J. Diabetes mellitus and its degenerative complications a prospective study of 4,400 patients observed between 1947 and 1973 . Diabetes Care. 1:1978;168-188.
3. Fagerberg S.E. Diabetic neuropathy a clinical and histological study on the significance of vascular affections . Acta Med Scand. 164:(suppl 345):1959;1-97.
4. Raskin P. Diabetic regulation and its relationship to microangiopathy. Metabolism. 27:1978;235-252.
5. Porte D., Graf R.J., Halter J.B., et al. Diabetic neuropathy and plasma glucose control. Am J Med. 70:1981;195-200.
6. Gregersen G. Diabetic neuropathy influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity . Neurology. 17:1967;972-980.
7. Graf R.J., Halter J.B., Pfeifer M.A., et al. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects. Ann Intern Med. 94:1981;307-311.
8. Ziegler D., Mayer P., Muhlen H., Gries F.A. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type I (insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;822-829.
9. Holman R.R., Dornan T.L., Moyon-White V., et al. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients a two-year randomised prospective study . Lancet. 1:1983;204-208.
10. Service F.J., Daube J.R., O'Brien P.C., et al. Effect of blood glucose control on peripheral nerve function in diabetic patients. Mayo Clin Proc. 58:1983;283-289.
11. Dahl-Jorgensen K., Brinchmann-Hansen O., Hanssen K., et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy the Oslo study . BMJ. 293:1986;1195-1199.
12. Dahl-Jorgensen K. Near-normoglycemia and late diabetic complications the Oslo study . Acta Endocrinol. 115:(suppl 284):1987;1-56.
13. Krönert K., Hülser J., Luft D., et al. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction. J Clin Endocrinol Metab. 64:1987;1219-1223.
14. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
15. Factors in development of diabetic neuropathy baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial . Diabetes. 37:1988;476-481.
16. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care. 11:1988;725-732.
17. Haug P.H., Kelly T.M., Cannon R.B., Edwards C.Q. A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy. J Neurol Sci. 82:1987;123-132.
18. Llewelyn J.G., Thomas P.K., Fonseca V., et al. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl). 72:1986;157-163.
19. Potter C.G., Sharma A.K., Farber M.O., Peterson R.G. Hypoglycemic neuropathy in experimental diabetes. J Neurol Sci. 88:1988;293-301.
20. Tze W.J., Sima A.A.F., Tai J. Effect of endocrine pancreas allotransplantation on diabetic nerve dysfunction. Metabolism. 34:1985;721-725.
21. Orloff M.J., Macedo A., Greenleaf G.E. Effect of pancreas transplantation on diabetic somatic neuropathy. Surgery. 104:1988;437-444.
22. Schmidt R.E., Plurad S.B., Olack B.J., Scharp D.W. The effect of pancreatic islet cell transplantation and insulin therapy on experimental diabetic autonomic neuropathy. Diabetes. 32:1983;532-540.
23. Solders G., Wilczek H., Gunnarsson R., et al. Effects of combined pancreatic and renal transplantation on diabetic neuropathy a two-year follow-up study . Lancet. 2:1987;1232-1235.
24. Kennedy W.R., Navarro X., Goetz F.C., et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 322:1990;1031-1037.
25. Navarro X., Sutherland D.E.R., Kennedy W.R. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol. 42:1997;727-736.
26. Navarro X., Kennedy W.R., Aeppli D., Sutherland D.E.R. Neuropathy and mortality in diabetes influence of pancreatic transplantation . Muscle Nerve. 19:1996;1009-1016.
27. +-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes. 37:1988;688-693.
28. Masson E.A., Boulton A.J.M. Aldose reductase inhibitors in the treatment of diabetic neuropathy a review of the rationale and clinical evidence . Drugs. 39:1990;190-202.
29. Nicolucci A., Farinci F., Cavaliere D., et al. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. Diabetic Med. 13:1996;1017-1026.